Cargando…

Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive and irreversible respiratory failure. Non-invasive markers of disease activity are essential for prognosis and evaluation of early response to anti-fibrotic treatments. OBJECTIVES: The aims of this study were to determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bondue, Benjamin, Castiaux, Amélie, Van Simaeys, Gaetan, Mathey, Céline, Sherer, Félicie, Egrise, Dominique, Lacroix, Simon, Huaux, François, Doumont, Gilles, Goldman, Serge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334423/ https://www.ncbi.nlm.nih.gov/pubmed/30646908 http://dx.doi.org/10.1186/s12931-019-0974-5

Ejemplares similares

N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by (89)Zr-Trastuzumab and (18)F-FDG PET imaging
por: Wimana, Zéna, et al.
Publicado: (2017)

Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis
por: Lavis, Philomène, et al.
Publicado: (2023)

Clinical experience with (18)F-JK-PSMA-7 when using a digital PET/CT
por: Vierasu, Irina, et al.
Publicado: (2022)

Recurrent ‘Occult’ (18)F-FDG Uptake in an Atypical Case of Anti-Myeloperoxidase Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Castiaux, Amélie, et al.
Publicado: (2022)

Bilateral cytomegalovirus infection of the adrenal glands revealed by (18)F‐FDG PET/CT in a patient with T‐cell lymphoma
por: Van Bogaert, Camille, et al.
Publicado: (2022)

Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience
por: Levra, Stefano, et al.
Publicado: (2022)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

A Handcrafted Radiomics-Based Model for the Diagnosis of Usual Interstitial Pneumonia in Patients with Idiopathic Pulmonary Fibrosis
por: Refaee, Turkey, et al.
Publicado: (2022)

Tristetraprolin regulation of interleukin 23 mRNA stability prevents a spontaneous inflammatory disease
por: Molle, Céline, et al.
Publicado: (2013)

Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry
por: Salisbury, Margaret L., et al.
Publicado: (2020)

Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation
por: Vu, Tuong N., et al.
Publicado: (2019)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2019)

Analyses of the Efficacy and Safety of Antifibrotic Therapies in Non-IPF Pulmonary Fibrosis, Progressing Despite Management
por: Wells, Athol U.
Publicado: (2022)

(18)F-JK-PSMA-7 PET/CT for staging intermediate- or high-risk prostate cancer patients before radical prostatectomy: a pilot study
por: Vierasu, Irina, et al.
Publicado: (2023)

Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
por: Finnerty, James Patrick, et al.
Publicado: (2021)

Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
por: Biondini, Davide, et al.
Publicado: (2021)

Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients
por: Win, Thida, et al.
Publicado: (2013)

Feeding and Stocking Up: Radio-Labelled Food Reveals Exchange Patterns in Ants
por: Buffin, Aurélie, et al.
Publicado: (2009)

Voxelwise Principal Component Analysis of Dynamic [S-Methyl-(11)C]Methionine PET Data in Glioma Patients
por: Martens, Corentin, et al.
Publicado: (2021)

Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis
por: Korfei, Martina, et al.
Publicado: (2018)

Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE
por: Kolonics-Farkas, Abigél M., et al.
Publicado: (2020)

The human box C/D snoRNAs U3 and U8 are required for pre-rRNA processing and tumorigenesis
por: Langhendries, Jean-Louis, et al.
Publicado: (2016)

Transplantable human thyroid organoids generated from embryonic stem cells to rescue hypothyroidism
por: Romitti, Mírian, et al.
Publicado: (2022)

Deep Learning for Reaction-Diffusion Glioma Growth Modeling: Towards a Fully Personalized Model?
por: Martens, Corentin, et al.
Publicado: (2022)

Antifibrotics in India
por: Dhar, Raja
Publicado: (2019)

Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFR(pos) Mouse Xenograft Model
por: Huet, Simon, et al.
Publicado: (2023)

Development of the ATAQ-IPF: a tool to assess quality of life in IPF
por: Swigris, Jeffrey J, et al.
Publicado: (2010)

Recommendations on treatment for IPF
por: Behr, Jürgen, et al.
Publicado: (2013)

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
por: Jo, Helen E., et al.
Publicado: (2019)

Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF
por: Tóth, Nóra Melinda, et al.
Publicado: (2023)

Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis
por: Chiavarina, Barbara, et al.
Publicado: (2021)

Pulmonary (18)F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF)
por: Win, Thida, et al.
Publicado: (2018)

The Elusive Antifibrotic Macrophage
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2015)

Highlights of HRCT imaging in IPF
por: Sverzellati, N
Publicado: (2013)

IPF - Idiopathic Pulmonary Fibrosis
Publicado: (2019)

The role of neutrophils in the pathogenesis of IPF
por: Jegal, Yangjin
Publicado: (2022)

Deciphering the Antifibrotic Property of Metformin
por: Septembre-Malaterre, Axelle, et al.
Publicado: (2022)

Rapidly non-ipf progressive fibrosing interstitial lung disease: a phenotype with an ipf-like behavior
por: Khine, Ngu, et al.
Publicado: (2020)

IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014)

Mitochondrial Quality Control in COPD and IPF
por: Hara, Hiromichi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jbhk71m8cqgcs96ihvkei4j396